Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain

NCT03181984 is registered in ClinicalTrials.gov with Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03181984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03181984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain
Lead sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2017
Completion date
April 19, 2023
Enrollment
501 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

port-wine stain